| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $879.7M | +6.1% |
| Cost of Revenue | $607.0M | +7.4% |
| Gross Profit | $272.6M | +3.3% |
| R&D Expense | $6.5M | -9.9% |
| SG&A Expense | $80.1M | +17.5% |
| Operating Income | $172.5M | +3.5% |
| Pre-tax Income | $115.4M | -17.0% |
| Income Tax | -$16.3M | -372.3% |
| Net Income | $123.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $94.4M | -51.8% |
| Accounts Receivable | $164.1M | -21.4% |
| Inventory | $38.1M | -15.4% |
| Current Assets | $547.1M | -15.3% |
| Total Assets | $5.67B | +8.8% |
| Current Liabilities | $598.1M | +11.4% |
| Long-term Debt | $2.34B | +17.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $410.9M | +32.8% |
| Capital Expenditures | $487.7M | -21.1% |
| Investing Cash Flow | -$780.3M | -24.2% |
| Financing Cash Flow | $287.9M | -24.2% |
| Free Cash Flow | -$76.8M | +75.2% |
| -0.5% |
| EPS (Basic) | $2.05 | -1.9% |
| EPS (Diluted) | $2.04 | -1.9% |
| Total Liabilities |
| $3.11B |
| +12.7% |
| Stockholders' Equity | $2.43B | +4.7% |